161 related articles for article (PubMed ID: 9188947)
1. Clinical efficacy and safety of local nasal immunotherapy.
Andri L; Senna GE; Dama AR
Allergy; 1997; 52(33 Suppl):36-9. PubMed ID: 9188947
[TBL] [Abstract][Full Text] [Related]
2. Specific nasal provocation test with powder allergen.
Salzano FA
Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946
[TBL] [Abstract][Full Text] [Related]
3. Short-term efficacy of nasal immunotherapy.
Palma-Carlos AG; Santos AS; Pregal A
Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
[TBL] [Abstract][Full Text] [Related]
4. Nasal application of immunotherapy.
Ascione E; De Lucia A; Imperiali M; Varricchio A; Motta G
Chem Immunol Allergy; 2003; 82():89-98. PubMed ID: 12947995
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
6. Nasal immunotherapy in pollen-sensitive children.
Cserháti E; Mezei G
Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
[TBL] [Abstract][Full Text] [Related]
7. Local nasal immunotherapy: experimental evidences and general considerations.
Passalacqua G; Albano M; Riccio AM; Scordamaglia A; Canonica GW
Allergy; 1997; 52(33 Suppl):10-6. PubMed ID: 9188941
[TBL] [Abstract][Full Text] [Related]
8. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form.
Andri L; Senna G; Andri G; Dama A; Givanni S; Betteli C; Dimitri G; Falagiani P; Mezzelani P
Clin Exp Allergy; 1995 Nov; 25(11):1092-9. PubMed ID: 8581842
[TBL] [Abstract][Full Text] [Related]
9. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
Esch RE; Bush RK; Peden D; Lockey RF
Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
Bertoni M; Cosmi F; Bianchi I; Di Berardino L
Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
12. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study.
Andri L; Senna G; Betteli C; Givanni S; Andri G; Dimitri G; Falagiani P; Mezzelani P
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):34-41. PubMed ID: 8568135
[TBL] [Abstract][Full Text] [Related]
13. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
14. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
Ariano R; Panzani RC; Chiapella M; Augeri G; Falagiani P
J Investig Allergol Clin Immunol; 1995; 5(3):126-32. PubMed ID: 7582157
[TBL] [Abstract][Full Text] [Related]
15. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
Fuchs T; Klimek L
HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
[No Abstract] [Full Text] [Related]
16. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract.
Andri L; Senna G; Betteli C; Givanni S; Andri G; Falagiani P
J Allergy Clin Immunol; 1993 May; 91(5):987-96. PubMed ID: 8491949
[TBL] [Abstract][Full Text] [Related]
17. Titration of immunotherapy by periodical nasal allergic challenges in the treatment of allergic rhinitis.
Clarke PS
Med J Aust; 1992 Jul; 157(1):11-3. PubMed ID: 1640882
[TBL] [Abstract][Full Text] [Related]
18. [Topical nasal hypersensitization in the treatment of perennial rhinitis, with water extracts of dust and Dermatophagoides. I. Preliminary study].
Campos A; Basomba A; Peláez A; García Villalmanzo I
Allergol Immunopathol (Madr); 1979; 7(3):217-22. PubMed ID: 474329
[No Abstract] [Full Text] [Related]
19. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation.
Passalacqua G; Albano M; Ruffoni S; Pronzato C; Riccio AM; Di Berardino L; Scordamaglia A; Canonica GW
Am J Respir Crit Care Med; 1995 Aug; 152(2):461-6. PubMed ID: 7633693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
